MDWD - MediWound - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

32.62M

Cash

51.12M

Avg Qtr Burn

-1.791M

Short % of Float

0.62%

Insider Ownership

24.24%

Institutional Own.

29.61%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NexoBrid Details Eschar removal, Thermal burns	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EscharEx Details Venous Leg Ulcers	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MW005 Details Basal cell carcinoma, Cancer, Non-melanoma skin cancer, Skin cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.